Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

October 16, 2019

CRISPR, KSQ Therapeutics join forces to advance cell therapies in oncology

CRISPR Therapeutics and KSQ Therapeutics have signed license agreement to advance their respective cell therapy programmes in oncology.

CRISPR, KSQ Therapeutics join forces to advance cell therapies in oncology